Barclays lowered the firm’s price target on Emerson (EMR) to $140 from $145 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the multi-industry group as part of a Q1 earnings preview. The sector faces “more demand question marks” but expectations are “somewhat re-based,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: